IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans

IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans

Source: 
Clinical Trials Arena
snippet: 

IDEAYA Bioscience’s rare cancer drug shows benefit in interim Phase II data, with the company announcing the drugs Phase III trial design.